3 Point Analysis | Hikal Q2 Review

Moneycontrol 2019-10-30

Views 3

Hikal ltd the emerging Pharma and chemicals company, had a catastrophic quarter marred by operational challenges, Sakshi Batra does a 3 point analysis to understand the earnings fine print and the outlook on the company.
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
3 Point Analysis | What should investors do with IndusInd bank post Q2 results
play
02:32

3 Point Analysis | What should investors do with IndusInd bank post Q2 results
3 Point Analysis | Tata Chemicals Q2 Review
play
02:21

3 Point Analysis | Tata Chemicals Q2 Review
3 Point Analysis | Shoppers Stop Q2 Review
play
02:47

3 Point Analysis | Shoppers Stop Q2 Review
3 Point Analysis | IHCL Q2 Review
play
02:10

3 Point Analysis | IHCL Q2 Review
3 Point Analysis | Wipro Q2 Review
play
02:53

3 Point Analysis | Wipro Q2 Review
3 Point Analysis | L&T Infotech Q2 Review
play
02:47

3 Point Analysis | L&T Infotech Q2 Review
3 Point Analysis | Key Insights From Q2 results so far
play
03:04

3 Point Analysis | Key Insights From Q2 results so far
3 Point Analysis | Tata Motors Q2 results recorded strong performance by JLR
play
01:52

3 Point Analysis | Tata Motors Q2 results recorded strong performance by JLR
3 Point Analysis | Mindtree Q2 Review
play
02:40

3 Point Analysis | Mindtree Q2 Review
3 Point Analysis | Will Q2 earnings lift market sentiment?
play
03:47

3 Point Analysis | Will Q2 earnings lift market sentiment?
3 Point Analysis | Sequent Scientific Q2 Review
play
03:18

3 Point Analysis | Sequent Scientific Q2 Review
3 Point Analysis | Petronet LNG Q2 FY20 Review
play
02:44

3 Point Analysis | Petronet LNG Q2 FY20 Review